The Role of Transforming Growth Factor β in Lung Development and Disease

Transforming growth factor (TGF) β plays an important role in normal pulmonary morphogenesis and function and in the pathogenesis of lung disease. The effect of TGFβ is regulated via a selective pathway of TGFβ synthesis and signaling that involves activation of latent TGFβ, specific TGFβ receptors, and intracellular signaling via Smad molecules. All three isoforms of TGFβ are expressed at high levels during normal lung development, being particularly important for branching morphogenesis and epithelial cell differentiation with maturation of surfactant synthesis. Small amounts of TGFβ are still present in the adult lung, and TGFβ is involved in normal tissue repair following lung injury. However, in a variety of forms of pulmonary pathology, the expression of TGFβ is increased. These include chronic lung disease of prematurity as well as several forms of acute and chronic adult lung disease. While TGFβ1 appears to be the predominant isoform involved, elevated levels of all three isoforms have been demonstrated. The increase in TGFβ precedes abnormalities in lung function and detectable lung pathology, but correlates with the severity of the disease. TGFβ plays a key role in mediating fibrotic tissue remodeling by increasing the production and decreasing the degradation of connective tissue via several mechanisms.

[1]  D. Remick,et al.  Radiation-induced lung injury in vivo: Expression of transforming growth factor—Beta precedes fibrosis , 1996, Inflammation.

[2]  M. Huang,et al.  Interferon-alpha inhibits murine macrophage transforming growth factor-beta mRNA expression , 1994, Inflammation.

[3]  E. Masliah,et al.  Keratinocyte Growth Factor Decreases Pulmonary Edema, Transforming Growth Factor-Beta and Platelet-Derived Growth Factor-BB Expression, and Alveolar Type II Cell Loss in Bleomycin-Induced Lung Injury , 1998, Inflammation.

[4]  C. Speer,et al.  New Insights into the Pathogenesis of Pulmonary Inflammation in Preterm Infants , 2001, Neonatology.

[5]  O. Eickelberg,et al.  Molecular mechanisms of TGF‐β antagonism by interferon γ and cyclosporine A in lung fibroblasts , 2001 .

[6]  G. Rosen,et al.  PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. , 2001, The American journal of pathology.

[7]  M. Nishimura,et al.  Ventilator-Induced Lung Injury Is Associated with Neutrophil Infiltration, Macrophage Activation, and TGF-&bgr;1 mRNA Upregulation in Rat Lungs , 2001 .

[8]  Cheng-Ming Li,et al.  TGF-β1 and fibroblast growth factor-1 modify fibroblast growth factor-2 production in type II cells , 2000 .

[9]  R. Wells V. TGF-β signaling pathways , 2000 .

[10]  Yun M. Zhao,et al.  Expression of Transforming Growth Factor-β Type I and Type II Receptors Is Altered in Rat Lungs Undergoing Bleomycin-Induced Pulmonary Fibrosis☆ , 2000 .

[11]  J. Briegel,et al.  Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. , 2000, Transplantation.

[12]  P. Ballard,et al.  Transforming growth factor-β1 regulation of surfactant protein B gene expression is mediated by protein kinase-dependent intracellular translocation of thyroid transcription factor-1 and hepatocyte nuclear factor 3 , 2000 .

[13]  M. Schwarz,et al.  TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis , 2000, Thorax.

[14]  G. Laurent,et al.  Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. , 2000, American journal of respiratory and critical care medicine.

[15]  D. Warburton,et al.  Bioactive Transforming Growth Factor-Beta in the Lungs of Extremely Low Birthweight Neonates Predicts the Need for Home Oxygen Supplementation , 2000, Neonatology.

[16]  J. Murphy-Ullrich,et al.  Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology , 2000 .

[17]  C. Heldin,et al.  Specificity, diversity, and regulation in TGF‐β superfamily signaling , 1999 .

[18]  M. Yamakido,et al.  Expression of transforming growth factor‐β1 and tumour necrosis factor‐α in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin , 1999, Respirology.

[19]  Yan Zhang,et al.  Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. , 1999, Journal of immunology.

[20]  W. Mosgoeller,et al.  Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. , 1999, The European respiratory journal.

[21]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[22]  S. Iyer,et al.  Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. , 1999, The Journal of pharmacology and experimental therapeutics.

[23]  Qingjian Wang,et al.  Reduction of bleomycin induced lung fibrosis by transforming growth factor β soluble receptor in hamsters , 1999, Thorax.

[24]  D. Warburton,et al.  Adenovirus-mediated decorin gene transfer prevents TGF-β-induced inhibition of lung morphogenesis. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[25]  S. Jakowlew,et al.  Human Pulmonary Acinar Aplasia: Reduction of Transforming Growth Factor-β Ligands and Receptors , 1999, Pediatric Research.

[26]  K. Miyazono,et al.  Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. , 1999, The Journal of clinical investigation.

[27]  C. S. Campbell,et al.  Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[29]  S. Fujino,et al.  Role of transforming growth factor-beta1 and decorin in development of central fibrosis in pulmonary adenocarcinoma. , 1999, Human pathology.

[30]  R. Bone,et al.  REGULATION OF EXTRACELLULAR MATRIX PROTEINS BY TRANSFORMING GROWTH FACTOR β1IN CULTURED PULMONARY ENDOTHELIAL CELLS , 1999 .

[31]  S. Phan,et al.  Inhibition of Myofibroblast Apoptosis by Transforming Growth Factor β1 , 1999 .

[32]  N. Willich,et al.  Dose-dependent induction of transforming growth factor β (TGF-β) in the lung tissue of fibrosis-prone mice after thoracic irradiation , 1999 .

[33]  P. Hiemstra,et al.  Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease , 1998 .

[34]  W. Banks,et al.  Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. , 1998, Experimental lung research.

[35]  J. Rosenbloom,et al.  TGF-β1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[36]  P. Hasleton,et al.  Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. , 1998, Transplantation.

[37]  M. Copin,et al.  Transforming growth factor-β 1 in sarcoidosis , 1998 .

[38]  F. Graham,et al.  Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. , 1998, The American journal of pathology.

[39]  B. Voß,et al.  Supernatants from quartz dust treated human macrophages stimulate cell proliferation of different human lung cells as well as collagen-synthesis of human diploid lung fibroblasts in vitro. , 1998, Toxicology letters.

[40]  M. Stern,et al.  Peaks of transforming growth factor-beta mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. , 1998, Transplantation.

[41]  D. Warburton,et al.  Epithelium-specific adenoviral transfer of a dominant-negative mutant TGF-β type II receptor stimulates embryonic lung branching morphogenesis in culture and potentiates EGF and PDGF-AA , 1998, Mechanisms of Development.

[42]  G. Gurujeyalakshmi,et al.  Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. , 1998, American journal of respiratory cell and molecular biology.

[43]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[44]  B. He,et al.  [The therapeutic effect of TGF-beta monoclonal antibody to bleomycin-induced pulmonary fibrosis in rats]. , 1997, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[45]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[46]  T. Lee,et al.  Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. , 1997, Environmental health perspectives.

[47]  J. Bousquet,et al.  Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis , 1997 .

[48]  W. Border,et al.  Transforming growth factor-β in human glomerular injury , 1997 .

[49]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[50]  G. Buonocore,et al.  Bronchopulmonary dysplasia of the premature baby , 1997, Pediatric pulmonology.

[51]  A. Hata,et al.  TGF-β signalling through the Smad pathway , 1997 .

[52]  R. D. du Bois,et al.  Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. , 1997, The American journal of pathology.

[53]  K. Shirato,et al.  Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients. , 1997, The Tohoku journal of experimental medicine.

[54]  D. Remick,et al.  TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. , 1997, Journal of immunology.

[55]  J. Grande Role of Transforming Growth Factor-β in Tissue Injury and Repair , 1997 .

[56]  J. Grande Role of transforming growth factor-beta in tissue injury and repair. , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[57]  P. Sime,et al.  Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. , 1997, The American journal of pathology.

[58]  R. D. du Bois,et al.  Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lung. , 1996, The European respiratory journal.

[59]  D. Warburton,et al.  Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture. , 1996, Developmental biology.

[60]  T. Colby,et al.  Tissue localization of transforming growth factor-beta1 in pulmonary eosinophilic granuloma. , 1996, American journal of respiratory and critical care medicine.

[61]  T. Lee,et al.  Transforming growth factor-beta (TGF-beta) in silicosis. , 1996, American journal of respiratory and critical care medicine.

[62]  S. Phan,et al.  Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors* , 1996, The Journal of Biological Chemistry.

[63]  G. Raghu,et al.  Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. , 1996, American journal of respiratory cell and molecular biology.

[64]  Rakesh K. Kumar,et al.  Epithelial cell‐derived transforming growth factor‐β In bleomycin‐induced pulmonary injury , 1996, International journal of experimental pathology.

[65]  J. Whitsett,et al.  Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene. , 1996, Developmental biology.

[66]  L. Garbe,et al.  Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group. , 1996, American journal of respiratory and critical care medicine.

[67]  M. Silverman,et al.  Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. , 1996, The Journal of pediatrics.

[68]  H. Wiedemann Surfactant and acquired lung diseases. , 1996, Journal of Laboratory and Clinical Medicine.

[69]  K. Flanders,et al.  TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. , 1996, American journal of respiratory cell and molecular biology.

[70]  A. Desmoulière,et al.  Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. , 1995, American journal of respiratory and critical care medicine.

[71]  V. Kaartinen,et al.  Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction , 1995, Nature Genetics.

[72]  Álvaro R. Osornio-Vargas,et al.  Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro. , 1995, American journal of respiratory cell and molecular biology.

[73]  C. Strange,et al.  Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. , 1995, The Journal of rheumatology.

[74]  X. Liu,et al.  [The effect of transforming growth factor-beta on collagen expression by human embryonic fibroblasts]. , 1995, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[75]  A. Fine,et al.  Potential therapeutic initiatives for fibrogenic lung diseases. , 1995, Chest.

[76]  L. Gold,et al.  Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. , 1995, American journal of respiratory cell and molecular biology.

[77]  K. Flanders,et al.  Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. , 1995, The American journal of pathology.

[78]  G. Gurujeyalakshmi,et al.  Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. , 1995, Experimental lung research.

[79]  A. Ohta,et al.  Determination of various cytokines and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis: inverse correlation between type III procollagen aminopeptide and interferon-gamma in progressive patients. , 1995, British journal of rheumatology.

[80]  R. Watkins,et al.  Transforming growth factor-beta 1 modulates type II cell fibronectin and surfactant protein C expression. , 1994, The American journal of physiology.

[81]  B. Wallaert,et al.  Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. , 1994, American journal of respiratory and critical care medicine.

[82]  G. Sempowski,et al.  Expression of TGF-beta isoforms by Thy-1+ and Thy-1- pulmonary fibroblast subsets: evidence for TGF-beta as a regulator of IL-1-dependent stimulation of IL-6. , 1994, Lymphokine and cytokine research.

[83]  G. Simonneau,et al.  Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells. , 1994, Thorax.

[84]  A. Brody,et al.  Distribution of transforming growth factor-beta 1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[85]  M. Denis Neutralization of transforming growth factor-beta 1 in a mouse model of immune-induced lung fibrosis. , 1994, Immunology.

[86]  H. Moses,et al.  TGF beta 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures. , 1994, Development.

[87]  W. Maniscalco,et al.  Transforming growth factor-beta induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells. , 1994, The American journal of physiology.

[88]  P. Rubin,et al.  Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis. , 1994, International journal of radiation oncology, biology, physics.

[89]  B. Corrin,et al.  Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders , 1994, Histopathology.

[90]  T. Colby,et al.  Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. , 1994, American journal of respiratory and critical care medicine.

[91]  D. Hyde,et al.  Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. , 1993, Thorax.

[92]  M. Anscher,et al.  Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer , 1993 .

[93]  T. Lee,et al.  Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. , 1993, Journal of immunology.

[94]  F. Paliogianni,et al.  Effect of transforming growth factor-beta on early and late activation events in human T cells. , 1993, Journal of immunology.

[95]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[96]  L. Moreland,et al.  Transforming growth factor β within fibrotic scleroderma lungs , 1992 .

[97]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.

[98]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[99]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[100]  Y. Deguchi Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung. , 1992, Annals of the rheumatic diseases.

[101]  S. Kunkel,et al.  Lung cytokine production in bleomycin-induced pulmonary fibrosis. , 1992, Experimental lung research.

[102]  Mahlon D. Johnson,et al.  Expression of Transforming Growth Factor-β1, -β2, and -β3 mRNA and Protein in the Murine Lung , 1991 .

[103]  T. Colby,et al.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[104]  K. Flanders,et al.  Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. , 1991, American journal of respiratory cell and molecular biology.

[105]  T. Colby,et al.  Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders. , 1991, Chest.

[106]  A. A. W. Have-Opbroek,et al.  Lung development in the mouse embryo. , 1991 .

[107]  P. Schmid,et al.  Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. , 1991, Development.

[108]  S. Phan,et al.  Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin. , 1991, The Journal of clinical investigation.

[109]  H. Moses,et al.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension. , 1990, The Journal of clinical investigation.

[110]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[111]  L. A. Thet,et al.  Effect of transforming growth factor beta on synthesis of glycosaminoglycans by human lung fibroblasts. , 1990, Experimental lung research.

[112]  M. Sporn,et al.  Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis. , 1990, Development.

[113]  M. Sporn,et al.  Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation , 1989, The Journal of experimental medicine.

[114]  G. Raghu,et al.  Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-beta. , 1989, The American review of respiratory disease.

[115]  S. Rannels,et al.  Influence of the extracellular matrix on type 2 cell differentiation. , 1989, Chest.

[116]  J. Wrana,et al.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. , 1989, The Journal of biological chemistry.

[117]  J. Massagué,et al.  Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. , 1989, The Journal of biological chemistry.

[118]  R. Crystal,et al.  Alveolar macrophages release an insulin-like growth factor I-type molecule. , 1988, The Journal of clinical investigation.

[119]  S. Yasui,et al.  Bleomycin-stimulated hamster alveolar macrophages release interleukin-1. , 1988, The American journal of pathology.

[120]  J. Lazo,et al.  Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. , 1988, The Journal of pharmacology and experimental therapeutics.

[121]  M. Jordana,et al.  Spontaneous in vitro release of alveolar-macrophage cytokines after the intratracheal instillation of bleomycin in rats. Characterization and kinetic studies. , 1988, The American review of respiratory disease.

[122]  H. Moses,et al.  Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. , 1988, The Journal of biological chemistry.

[123]  J. Massagué,et al.  Cell adhesion protein receptors as targets for transforming growth factor-β action , 1987, Cell.

[124]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[125]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[126]  M. Lieberman,et al.  Differential effects of epidermal growth factor and transforming growth factor-beta on synthesis of Mr = 35,000 surfactant-associated protein in fetal lung. , 1987, The Journal of biological chemistry.

[127]  M. Laiho,et al.  Transforming growth factor‐beta is a strong and fast acting positive regulator of the level of type‐1 plasminogen activator inhibitor mRNA in WI‐38 human lung fibroblasts. , 1987, The EMBO journal.

[128]  A. Fine,et al.  The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. , 1987, The Journal of biological chemistry.

[129]  H. Moses,et al.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta , 1987, Journal of Experimental Medicine.

[130]  E. Kovacs,et al.  Intra-alveolar release of a competence-type growth factor after lung injury. , 2015, The American review of respiratory disease.

[131]  M. Sporn,et al.  Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. , 1986, Journal of immunology.

[132]  M. Laiho,et al.  Enhanced production and extracellular deposition of the endothelial- type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta , 1986, The Journal of cell biology.

[133]  D. Hill,et al.  Bi‐functional action of transforming growth factor‐β on DNA synthesis in early passage human fetal fibroblasts , 1986, Journal of cellular physiology.

[134]  M. Sporn,et al.  Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. , 1986, Journal of immunology.

[135]  R. Derynck,et al.  Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7 , 1986, Somatic cell and molecular genetics.

[136]  H. Moses,et al.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[137]  M. Sporn,et al.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[138]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[139]  John D. Johnson,et al.  Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. , 2015, The American review of respiratory disease.

[140]  R. Crystal,et al.  Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor. , 1984, The American review of respiratory disease.